Approved claims for menopause supplements mean something quite specific in Korea — and something quite different from what the same word means in the country you came from. A bottle on a Seoul pharmacy shelf and a bottle shipped from a US warehouse can carry similar-sounding promises while sitting under regulatory systems that barely resemble each other.
I assumed “approved” translated cleanly across borders, and that a stricter system simply meant better products. Reading the three frameworks side by side, neither assumption held. They aren’t answering the same question.
The United States: nobody approved that claim
This surprises people who assume the opposite.
Under the Dietary Supplement Health and Education Act, structure/function claims on supplement labels are not approved by the FDA and require no FDA evaluation before use[1]. The manufacturer must hold substantiation that the claim is truthful and not misleading, but does not submit that evidence to the agency[2]. Notification goes to the FDA within 30 days *after* the product is already on the market — a procedural step, not an authorisation[2].
That is why every such label carries the same sentence: the statement has not been evaluated by the FDA, and the product is not intended to diagnose, treat, cure or prevent any disease[2]. Only a drug may make that kind of claim[2].
So when an American product says something encouraging about menopause, no regulator signed off. The company decided the wording was defensible.
The European Union: assessed, and mostly not authorised
The EU took the opposite approach and ran into a different problem.
Under the nutrition and health claims regulation, claims require scientific authorisation. EFSA completed its evaluation of prioritised general-function claims and published 341 opinions covering 2,758 claims[3]. Most did not survive.
Then came the impasse. 1,548 botanical-related claims were placed on hold pending further consideration by the Commission and Member States[3] — and they have largely stayed there since 2012. Plant-derived ingredients, which is most of what fills the menopause category, ended up in a holding pattern rather than approved or rejected.
The practical effect: a European label may say very little, not because the ingredient failed, but because the question was never finished.
Korea: the ingredient clears the bar before it reaches the shelf
Korea sits in neither camp.
Here, a health functional food is a product made with ingredients whose functionality and safety have been recognised by the Ministry of Food and Drug Safety[4]. The package carries a designated mark, and the approved function is stated on the label[4].
Functions fall into three categories[4]:
- Nutrient function — the role of vitamins, minerals and similar nutrients
- Physiological activity function — may help maintain or improve health
- Disease risk reduction function — may help reduce the risk of a disease
Menopause-related ingredients sit almost entirely in the second category, which is why approved wording ends with “may help” rather than a flat assertion. That hedge isn’t timidity. It matches the evidence level the category was approved on.
Ingredients come in two forms[5]:
- Notified ingredients — listed in the official standards, usable by any manufacturer meeting the specifications. Roughly 95 are registered.
- Individually recognised ingredients — reviewed case by case, usable only by the company that obtained the recognition.
Worth noting, since the marketing often implies otherwise: individual recognition confers an exclusive right, not a higher evidence grade. After enough time and commercial track record, such ingredients can move onto the notified list.
What Korean law will not approve, by design
Here is the provision that explains a lot of otherwise puzzling label language.
Under Korea’s health functional food legislation, ingredients or components with disease treatment or prevention effects, or with functions related to sex, cannot be recognised[6]. It is written into the statute, not left to case-by-case discretion.
Two consequences follow for anyone comparing labels across countries.
First, if a Korean product hints at treating a condition, that wording is outside the approved scope regardless of what the box looks like. Second, claims you may be used to seeing on imported products cannot legally appear on a Korean label — not because Korean regulators judged the evidence weaker, but because that entire claim category is closed here.
This is the single most useful thing to understand when you are comparing a Korean product against one from home. You are not looking at two verdicts on the same question. You are looking at outputs from systems that ask different questions and permit different answers.
Which ingredients carry the menopause function here
The MFDS publishes a dedicated evaluation guide for the menopausal women’s health functionality, setting out the standards applied in review, and maintains a public page listing ingredients recognised for it[7].
Both categories are represented. Red ginseng and Sophora fruit extract appear among notified ingredients; individually recognised ones have included *Lactobacillus acidophilus* YT1, rhubarb root extract, a Cynanchum wilfordii-based complex extract, pomegranate extract and concentrate, Schisandra extract and fenugreek seed extract, among others.
The list changes. Ingredients are added, and reassessment can alter or remove entries — the standards were amended as recently as June 2026. Check the official database at the time of purchase rather than trusting any article’s list, including this one.
Note also that soy isoflavone, probably the ingredient most associated with menopause in popular understanding, is recognised in Korea under joint and bone health, not menopausal women’s health. Same ingredient, different approved function.
Checking a product yourself
A workable sequence for a Korean shelf:
- **Look for the health functional food mark.** Without it, the product is ordinary food and cannot carry a functional claim at all.
- **Read the stated function, not the front panel.** The mark alone doesn’t tell you the product was approved *for menopause*. An eye health product carries the same mark.
- **Find the functional ingredient and its daily intake** on the back panel.
- **Compare the front to the back.** Whatever the front says beyond the back panel wording is marketing.
- **Look up the ingredient** on the MFDS public food safety portal to read the recognised wording in its original form[7].
For imported products, add one step: the claim on that label reflects its country of origin’s rules, not Korea’s. A US structure/function claim carries an explicit statement that no regulator evaluated it.
Closing
None of this makes one system superior. The US framework favours market access and puts the burden on manufacturers after the fact. The EU insists on scientific authorisation and has ended up with a large backlog. Korea approves the ingredient in advance, with a narrow approved sentence and statutory exclusions.
What I had wrong was thinking a stricter regime meant a better bottle. It doesn’t follow. What Korea’s mark tells you is that this ingredient cleared a defined bar for a defined function — which is genuinely useful information, and also much narrower than the front of the box tends to suggest.
At a Glance
- US structure/function claims are not FDA-approved; notification occurs after marketing and a disclaimer is mandatory
- EFSA published 341 opinions on 2,758 general-function claims; 1,548 botanical claims remain on hold since 2012
- Korea recognises the ingredient in advance, with a fixed approved wording and a designated package mark
- Korean functions divide into nutrient, physiological activity, and disease risk reduction — menopause ingredients sit in the second
- Disease treatment or prevention, and sex-related functions, cannot be recognised under Korean statute
- Soy isoflavone is recognised in Korea for joint and bone health, not menopausal women’s health
- Recognised ingredient lists change; verify on the official portal at purchase
※ This article is for general information and does not replace medical advice, diagnosis or treatment. Regulations and recognised ingredient lists are amended periodically — confirm current details on official government sources before purchasing. If you have a history of hormone-sensitive conditions or are taking prescription medication, please consult a clinician before starting any supplement.
References
- US FDA, “Questions and Answers on Dietary Supplements”, https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
- US FDA, “Structure/Function Claims”, https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/structurefunction-claims
- EFSA, “Health claims (art. 13)”, https://www.efsa.europa.eu/en/topics/health-claims-art-13
- Korea Disease Control and Prevention Agency, National Health Information Portal — Health Functional Foods, https://health.kdca.go.kr/healthinfo/biz/health/gnrlzHealthInfo/gnrlzHealthInfo/gnrlzHealthInfoView.do?cntnts_sn=6548
- Food Safety Korea (MFDS), guidance on functional ingredients, https://www.foodsafetykorea.go.kr/portal/board/boardDetail.do?menu_no=3811&bbs_no=bbs464&ntctxt_no=1070220
- Korea Ministry of Government Legislation, Easy Law — Health Functional Food Act, standards for functional ingredients (Article 15), https://easylaw.go.kr/CSP/CnpClsMain.laf?popMenu=ov&csmSeq=1006&ccfNo=2&cciNo=1&cnpClsNo=1
- Food Safety Korea (MFDS), menopausal women’s health functionality information, https://www.foodsafetykorea.go.kr/portal/healthyfoodlife/functionalityView.do?viewNo=23